These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3510572)

  • 1. Antidepressant effects of carbamazepine.
    Post RM; Uhde TW; Roy-Byrne PP; Joffe RT
    Am J Psychiatry; 1986 Jan; 143(1):29-34. PubMed ID: 3510572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbamazepine versus lithium in mania: a double-blind study.
    Lerer B; Moore N; Meyendorff E; Cho SR; Gershon S
    J Clin Psychiatry; 1987 Mar; 48(3):89-93. PubMed ID: 3546274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbamazepine in manic-depressive illness: a new treatment.
    Ballenger JC; Post RM
    Am J Psychiatry; 1980 Jul; 137(7):782-90. PubMed ID: 7386656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of carbamazepine on body weight in affectively ill patients.
    Joffe RT; Post RM; Uhde TW
    J Clin Psychiatry; 1986 Jun; 47(6):313-4. PubMed ID: 3711029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic efficacy of carbamazepine in manic-depressive illness.
    Post RM; Uhde TW; Ballenger JC; Squillace KM
    Am J Psychiatry; 1983 Dec; 140(12):1602-4. PubMed ID: 6139957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression.
    Kramlinger KG; Post RM
    Arch Gen Psychiatry; 1989 Sep; 46(9):794-800. PubMed ID: 2505730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic and prophylactic effects of carbamazepine in bipolar disorders.
    Okuma T
    Psychiatr Clin North Am; 1983 Mar; 6(1):157-74. PubMed ID: 6351033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of carbamazepine in affective illness: a preliminary report.
    Ballenger JC; Post RM
    Commun Psychopharmacol; 1978; 2(2):159-75. PubMed ID: 352607
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder.
    Hirschfeld RM; Kasper S
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):507-22. PubMed ID: 15458610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of carbamazepine on serum electrolytes in affectively ill patients.
    Joffe RT; Post RM; Uhde TW
    Psychol Med; 1986 May; 16(2):331-5. PubMed ID: 3726007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.
    Denicoff KD; Smith-Jackson EE; Disney ER; Ali SO; Leverich GS; Post RM
    J Clin Psychiatry; 1997 Nov; 58(11):470-8. PubMed ID: 9413412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness.
    Okuma T; Inanaga K; Otsuki S; Sarai K; Takahashi R; Hazama H; Mori A; Watanabe S
    Psychopharmacology (Berl); 1981; 73(1):95-6. PubMed ID: 6785799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients.
    Placidi GF; Lenzi A; Lazzerini F; Cassano GB; Akiskal HS
    J Clin Psychiatry; 1986 Oct; 47(10):490-4. PubMed ID: 3093468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder.
    Calabrese JR; Delucchi GA
    Am J Psychiatry; 1990 Apr; 147(4):431-4. PubMed ID: 2107762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
    Ketter TA; Post RM; Parekh PI; Worthington K
    J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbamazepine in treatment and prophylaxis of manic-depressive disorder.
    Strömgren LS; Boller S
    Psychiatr Dev; 1985; 3(4):349-67. PubMed ID: 3912763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine in the prophylaxis of mood disorders.
    Stuppaeck C; Barnas C; Miller C; Schwitzer J; Fleischhacker WW
    J Clin Psychopharmacol; 1990 Feb; 10(1):39-42. PubMed ID: 2307735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, controlled trial of inositol treatment of depression.
    Levine J; Barak Y; Gonzalves M; Szor H; Elizur A; Kofman O; Belmaker RH
    Am J Psychiatry; 1995 May; 152(5):792-4. PubMed ID: 7726322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of carbamazepine in psychiatric disorders.
    Birkhimer LJ; Curtis JL; Jann MW
    Clin Pharm; 1985; 4(4):425-34. PubMed ID: 2864160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.